| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Alveolar epithelial cells (AEC) are directly exposed to high alveolar O2 tension. Many pulmonary disorders are associated with a decrease in alveolar O2 tension and AEC need to develop adaptative mechanisms to cope with O2 deprivation. Under hypoxia, because of inhibition of oxidative phosphorylation, adenosine triphosphate supply is dependent on the ability of cells to increase anaerobic glycolysis. In this study we show that under hypoxia, primary rat AEC maintained their energy status close to that of normoxic cells through increasing anaerobic glycolysis. We therefore examined the effect of hypoxia on glucose transport and evaluated the mechanisms of this regulation. Hypoxia induced a stimulation of Na-independent glucose transport, as shown by the increase in 2-deoxy-D-glucose (DG) uptake. This increase was dependent on time and O2 concentration: maximal at 0% O2 for 18 h, and reversible after hypoxic cells were allowed to recover in normoxia. Concomitantly, exposure of AEC to hypoxia (18 h 0% O2) induced a 3-fold increase of glucose transporter GLUT1 at both protein and messenger RNA (mRNA) levels. To determine whether the increase in GLUT1 mRNA level was dependent on O2 deprivation per se or resulted from decrease of oxidative phosphorylation, we examined in normoxic cells the effects of cobalt chloride and Na azide, respectively. Cobalt chloride (100 µM) and Na azide (1 mM) increased both mRNA levels and DG uptake, mimicking the effect of hypoxia. Electrophoretic mobility shift assays revealed a hypoxic and a cobalt chloride induction of a hypoxia-inducible factor (HIF) that bound to the sequence of nucleotides, corresponding to a hypoxia-inducible element upstream of the GLUT1 gene. AEC also expressed this factor under nonhypoxic conditions. Together, our results demonstrate that AEC increased glucose transport in response to hypoxia by regulating GLUT1 gene-encoding protein. This regulation likely occurred at the transcriptional level through the activation of an HIF, the nature of which remains to be elucidated.
| |
Introduction |
|---|
|
|
|---|
Owing to its situation, alveolar epithelium is in situ exposed to high O2 tension: alveolar PO2 ~ 100 mm Hg. However, a decrease in alveolar O2 tension is observed under diverse conditions. Alveolar hypoxia may be the consequence of a decrease in O2 tension in the inspired gas (as observed during high-altitude ascent) or may result from localized or generalized ventilatory defect in various respiratory disorders. Alveolar type II cells are the most abundant alveolar epithelial cells (AEC) and they play a vital role in respiratory mechanics and gas exchange because they synthesize and secrete surfactant, replace alveolar type I cells in injured alveolar epithelium, and maintain alveolar space free of fluid by transporting Na actively from the alveolar to the interstitial space. Maintenance of these functions during alveolar hypoxia depends on the ability of AEC to develop adaptative strategies to overcome O2 deprivation. Little information is available about the cellular adaptation of AEC to hypoxia. There is some evidence that AEC are fairly tolerant to severe hypoxia, surviving at least 24 h without cellular damage (1, 2). However, the demonstrated decrease in functional expression of Na transport proteins in AEC after hypoxia (1) raises the question of their ability to cope with O2 deprivation.
In diverse tissues and cell types, tolerance to hypoxia has been assumed to be the result of maintenance of adequate energy supply under hypoxia despite the reduction of oxidative phosphorylation (3). To do so, the cells dramatically increased anaerobic glycolysis by upregulating the expression and the activity of glycolytic enzymes (4) and increasing glucose transport at the membrane level. AEC under normoxic conditions display a very high aerobic and anaerobic glycolytic (2). Because the rate of glycolytic enzymes largely exceeds glucose utilization, glucose transport is, in normoxia, the main rate-limiting step for its metabolism (5). Under hypoxia, even though the activity of glycolytic enzymes is upregulated, the increase in glycolysis will be efficient only if a parallel increase in glucose transport occurs. The goal of this study was to evaluate whether, in AEC, hypoxia regulates activity and expression of glucose transport, and to determine the mechanisms involved in this regulation. Our results indicate that hypoxia increases activity of the Na-independent glucose transport in an O2 concentration-dependent and time-dependent manner, an effect that is reversible after reoxygenation. The increase in glucose transport was dependent on protein synthesis and associated with an increase in GLUT1 protein units at the membrane level. Concomitantly, hypoxia upregulated GLUT1 messenger RNA (mRNA) transcript through two distinct O2 deprivation regulatory pathways and increased the DNA binding activity of hypoxia-inducible factor (HIF), which suggest that this gene regulation occurred at the transcriptional level.
| |
Materials and Methods |
|---|
|
|
|---|
Cell Isolation
Alveolar type II cells were isolated from pathogen-free,
male Sprague-Dawley rats (200 to 250 g) as previously described (6). Briefly, pooled cells from three rats were prepared as follows. Rats were injected with 30 mg/kg pentobarbital sodium intraperitoneally and 1 U/g heparin sodium
intravenously. After a tracheotomy was performed, the animal was exsanguinated. Solution II (40 to 50 ml), which
contained (in mM) 140 NaCl, 5 KCl, 2.5 sodium phosphate buffer, 10 N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid (Hepes), 2 CaCl2, and 1.3 MgSO4, pH 7.40, at
22°C, was perfused through the air-filled lungs via the pulmonary artery to clear the vascular space of blood. The
lungs were removed from the thorax and lavaged to total
lung capacity (8 to 10 ml) five times with Solution I, which
contained (in mM) 140 NaCl, 5 KCl, 2.5 sodium phosphate
buffer, 10 Hepes, 6 D-glucose, and 0.2 ethylene glycol- bis(
-aminoethyl ether)-N,N,N',N'-tetraacetic acid, to remove macrophages; and two times with Solution II. Then,
lungs were filled with 12 to 15 ml of elastase solution (porcine pancreas, twice-crystallized 40 U/ml, prepared in Solution II) and incubated in a shaking water bath in air for
10 min at 37°C, after which additional elastase solution was
instilled for another 10-min incubation. The lungs were
minced in the presence of DNAse I, and 5 ml of fetal bovine serum (FBS) was added to stop the effect of elastase.
The lungs were then sequentially filtered through 150- and
30-mm nylon mesh. The filtrate was centrifuged at 300 × g
for 8 min. The cell pellet was resuspended in Dulbecco's
modified Eagle's medium (DMEM) containing 25 mM D-glucose at 37°C. The cell supension was plated at a density of
106 cells/cm2 in 25 cm2 bacteriologic plastic dishes to aid in
the removal of macrophages by differential adherence. After incubation at 37°C in a 5% CO2 incubator for 1 h, the unattached cells in suspension were removed and centrifuged
at 300 × g for 8 min. The resulting cell pellet (70% purity, > 95% viability, 8 to 10 × 106 cells/rat) was plated at a density of 7 to 10 × 105 cells/cm2 in 6-, 12-, or 24-well culture
dishes. Culture medium consisted of DMEM containing 25 mM D-glucose, 10 mM Hepes, 23.8 mM NaHCO3, 2 mM
L-glutamine, 10% FBS, 50 U/ml penicillin, 50 µg/ml streptomycin, and 10 µg/ml gentamycin, and the pellet was incubated in a 5% CO2-95% air atmosphere. The cell purity after
24 h was 90 ± 2%, as assessed by a characteristic fluorescence
with phosphine 3R as previously described (6). Contaminating cells were essentially macrophages. Culture medium
was changed 24 h after isolation and then on alternate days.
Cells were used after 48 h in culture and were likely in
transition to type I AEC, thus they are designated AEC (7).
Hypoxic Exposure
Two days after plating, growth medium was removed and replaced by a thin layer of fresh medium (0.15 ml/cm2) with 10% FBS to decrease the diffusion distance of the ambient gas. To achieve hypoxic exposure, culture dishes were placed in a humidified, airtight incubator with inflow and outflow valves, and the hypoxic gas mixture (0% O2- 5% CO2-95% N2) was delivered at 10 liters/min for 20 min. The airtight incubator was kept at 37°C for 3, 6, 12, or 18 h and control normoxic cells were placed in a 5% CO2-21% O2-74% N2 humidified incubator for the same period of time. In additional experiments, exposure to a mild hypoxia mixture (5% O2-5% CO2-90% N2) was performed as described previously over an 18-h period. Oxygen tensions assayed in the culture medium were 30, 60, and 140 mm Hg after 18 h 0% O2 (severe hypoxia), 5% O2 (mild hypoxia), and 21% O2 (normoxia), respectively. In culture medium, pH measured at the end of exposure was not significantly different under normoxic and hypoxic conditions. Trypan blue exclusion measured in cells exposed to hypoxia did not decrease, as compared with normoxic controls. For hypoxia-reoxygenation experiments, cells were exposed to 18 h hypoxia, then placed in a 5% CO2-21% O2-74% N2 humidified incubator with the normoxic counterparts for 24 or 48 additional hours. Culture medium was changed at the end of hypoxia and at 24 h of reoxygenation. In additional experiments, cells were exposed for 18 h in normoxic conditions to cobalt chloride (100 µM) or to inhibitor of oxydative phosphorylation Na azide (1 mM).
Measurement of Glucose Transport
The measurement of glucose uptake was done as previously described (6). Uptake was determined immediately
after hypoxic exposure. The assays were performed at
37°C in a buffered solution of the following composition
(in mM): 137 NaCl, 5.4 KCl, 2.8 CaCl2, 1.2 MgSO4, and 14 Hepes (pH 7.4). In the sodium-free medium, sodium was
replaced by N-methyl-glucamine. After removal of the
culture medium, cells were washed twice with 1 ml/well of
the uptake solution, and were incubated for adequate periods of time in the presence of either [3H]deoxy-D-glucose
(DG) (0.5 µCi/ml), [14C]
-methyl-glucopyranoside (MGP),
or 3-O-[methyl-3H] glucose (1 µCi/ml) with appropriate concentrations of DG, MGP, or 3-O-methyl glucose (3 OMG).
At the end of the incubation, uptake was stopped by washing the cells three times with 1 ml/well of ice-cold solution
containing (in mM) 137 NaCl and 15 Hepes, pH 7.4. After
incubations, cells were solubilized in 0.5% Triton X-100.
Tracer activities were determined by liquid scintillation counting and the remaining volume of each sample was
used for assessing the protein content per well.
Measurement of Adenosine Triphosphate Contents
Adenosine triphosphate (ATP) content of cells exposed to
normoxia and hypoxia was determined enzymatically. After removal of the culture medium, cells were washed with
ice-cold solution containing (in mM) 14 Tris and 137 NaCl,
pH 7.4, and extracted with ice-cold 0.3 N perchloric acid.
Extracts were neutralized to pH 7 with potassium hydroxide. ATP was measured in the supernatant by bioluminescence using an ATP determination kit (Calbiochem Biochemicals, San Diego, CA) based on the light generation
reaction with luciferin and firefly luciferase. Measurements
were performed in a luminometer (Hewlett Packard Picolite Luminometer). Standard curves of log photons versus log ATP were linear over the range 10
8 to 10
5 M ATP.
Measurement of Lactate Content and Glucose Consumption
Glucose concentrations in the medium and lactate content of cells were determined by the glucose oxidase method and spectrophotometric analysis using lactate dehydrogenase, respectively (Sigma Chemical, St. Louis, MO). Protein was determined by the Bradford method.
Total Membrane Isolation and Western Blots
Confluent monolayers were rinsed twice with iced phosphate-buffered saline (PBS), pH 7.4, and scraped gently with
a rubber policeman in a Solution A containing 3 mM Tris
HCl and 1 mM ethylenediaminetetraacetic acid (EDTA).
All remaining steps were performed at 4°C. Cells were homogenized in a Dounce potter homogenizer (15 strokes). The homogenates were then centrifuged at 750 × g for 5 min
to remove nuclei and unbroken cells, and the supernatants
were centrifuged at 150,000 × g for 60 min. The resulting
pellets containing total cell membranes were routinely resuspended in a small volume of Solution A. The supernatants were frozen at
80°C until used. Protein was determined by the method of Bradford. Samples (30 µg) were
resolved in 12% sodium dodecyl sulfate polyacrylamide gel electrophoresis (PAGE), electrically transferred to nitrocellulose paper, and blocked for 1 h at 37°C in PBS-
milk (137 mM NaCl, 15.5 Na2PO4, pH 7.4, containing 50 mg/ml nonfat dry milk). Blots were then washed in PBS-
Tween (in mM: 137 NaCl, 15.4 Na2PO4, 1.4 KH2PO4, and
2.7 KCl) as well as 0.1% Tween-20, pH 7.4, and incubated
with antibody in PBS-milk (3 mg/ml) for 16 h at 4°C. The
following antibodies and dilutions were used: rabbit polyclonal anti-GLUT1 transporter directed against the C-terminus of rat GLUT1 coupled to KLH (Chemicon, Temecula, CA) 1:1,000, and actin, 1:5,000. Blots were washed and
incubated with an antirabbit antibody for 2 h at 23°C. Blots
were washed three times in PBS-Tween for 15 min each
and subjected to autoradiography using Kodak film. Quantification of GLUT1 and actin levels was obtained using
NYH software.
Ribonuclease Protection Assay
Cells in 35-mm plastic dishes were lysed in a buffer containing 4 M guanidium thiocyanate, 25 mM sodium citrate
(pH 7.0), and 0.5% sarcosyl, and directly used for ribonuclease (RNase) protection assay (RPA) as previously described (1). Total RNA equivalent of 106 cells or 20 mg of
yeast transfer RNA (Boehringer Mannheim, Indianapolis, IN) were cohybridized with 5 × 105 counts per minute
(cpm) for GLUT1, and 5 × 104 cpm for
-actin probes in
80% formamide, 40 mM 1,4-piperazine-diethanesulfonic acid (pH 7.4), 400 mM NaCl, and 1 mM EDTA at 50°C
overnight. RNase digestion (RNAse A, 40 mg/ml, and T1,
2 mg/ml; Boehringer) was performed at 30°C for 60 min,
then digestion with proteinase K (12.5 mg/ml; Boehringer)
was done at 37°C for 30 min. After phenol extraction and
ethanol precipitation, protected fragments were separated
by urea-PAGE. Gels were fixed with 10% acetic acid and vacuum-dried before exposure to Kodak X-OMAT AR 5 film, and signal was quantitated from the gel using direct
radioactivity measurement with an Instant Imager (Packard
Instrument Co., Meriden, CT). Actin expression was used
as an internal standard because neither hypoxia nor reoxygenation significantly modified the level of actin mRNA
measured in six independent experiments (1). Results were
expressed as the ratio of expression of the mRNA of interest to actin mRNA (arbitrary units [AU]).
Cellular RNA Probes
The GLUT1 probe was synthesized by reverse transcription
polymerase chain reaction from rat kidney mRNA from
pGEM Easy Vector Plasmid (Promega, Madison, WI). The
length of the GLUT1 probe was 336 bp (protected fragment
272 bp, corresponding to bp 486-758). The probe was located in the 3'-untranslated region. Mouse
-actin was synthesized using a complementary DNA insert in pGEM-3.
The probe was 190 bp long with a protected fragment of
135 bp (bp 696-831). Antisense RNA probes were synthesized using a T7 in vitro synthesis kit (Promega) in the
presence of [32P]uridine triphosphate (15 TBq/mmol).
Electrophoretic Mobility Shift Assays
Nuclear extracts were prepared as described by Semenza
and Wang (8). After exposure to 0% or 21% O2 for 6 h,
cells were washed twice with cold PBS, scraped into 5 ml
of PBS, and pelleted by centrifugation at 1,500 rpm for
5 min at 4°C. Nuclear extracts were prepared with Buffers
A and C containing 0.5 mM dithiothreitol (DTT), 0.4 mM
phenylmethylsulfonyl fluoride, 2 µg of leupeptin/ml, 2 µg
of aprotinin/ml, 2 µg of pepstatin/ml, and 1 mM sodium
vanadate. The cell pellet was washed with 4 packed-cell
volume (PCV) of Buffer A (10 mM Tris-HCl [pH 7.8], 1.5 mM MgCl2, and 10 mM KCl), resuspended in 4 PCV of
Buffer A, and incubated on ice for 10 min. The cell suspension was homogenized with a type B pestle and the nuclei were pelleted by centrifugation at 3,000 rpm for 5 min,
resuspended in 3 PCV of Buffer C (0.42 M KCl, 20 mM
Tris-HCl [pH 7.8], 1.5 mM MgCl2, and 20% glycerol), and
mixed on a rotator at 4°C for 30 min. Nuclear debris was
pelleted by centrifugation for 30 min at 13,500 rpm. The
supernatant was dialyzed against one change of Buffer D
(20 mM Tris-HCl [pH 7.8], 0.1 M KCl, 0.2 mM EDTA, and
20% glycerol) for a total of 3 h at 4°C. The dialysate was
centrifuged for 10 min at 13,500 rpm, and aliquots were
stored at
80°C. Protein concentration was determined by
the method of Bradford.
The oligonucleotide sequence for rat GLUT1 5' enhancer
was used as probe and competitors. The oligonucleotide
sequence was 5'-TCCACAGGCGTGCTGGCTGACACGCA-3' (9). Oligonucleotide probe was generated by the
5' labeling of the sense strand with
-[32P]ATP and T4
polynucleotide kinase, annealing to a 4-fold excess of unlabeled antisense strand. Binding reactions were carried out
in a total volume of 20 µl containing 5 µg of nuclear extract and 0.1 µg of denaturated calf thymus DNA in 10 mM Tris-HCl (pH 7.5), 50 mM KCl, 50 mM NaCl, 1 mM
MgCl2, 1 mM EDTA, 5 mM DTT, and 5% glycerol. After
incubation at room temperature, probe (104 cpm) was added
and the incubation was continued for an additional 15 min,
after which the reaction mixture was loaded onto 5% nondenaturating polyacrylamide gels. Electrophoresis was performed at 185 V in 0.3× Tris boric acid (TBE) (1 × TBE is
89 mM Tris-HCl, 89 mM boric acid, and 5 mM EDTA) at
4°C. Gels were vacuum-dried and autoradiographed with
intensifying screens at
80°C for 10 d. Competitor DNAs
were preincubated with nuclear extract and calf thymus
DNA for 5 min before addition of the labeled probe.
Materials
All chemicals were purchased from Sigma Chemical. Radioactive tracers were provided by Amersham (Aylesbury, UK). Culture media and reagents were from GIBCO BRL (Cergy-Pontoise, France). Plasticware was from Costar (Cambridge, MA).
Presentation of Data and Statistical Analysis
Uptakes of DG were expressed as nanomoles per milligram of protein. Results are presented as means ± standard error (SE) of three to six separate experiments in which triplicates were obtained. One-way or two-way variance analyses were performed and, when allowed by the F value, results were compared by the modified least significant difference.
| |
Results |
|---|
|
|
|---|
Effect of Hypoxia on ATP and Lactic Acid Contents
In AEC exposed to 0% O2 for increasing times, ATP content fell by about 60% of the control value after 3 h of exposure, then progressively increased, reaching normoxic values at 6 h of exposure to hypoxia. That AEC exposed to hypoxic conditions retained substantial store of ATP suggested a role for anaerobic glycolysis. Therefore, we examined lactic acid content of AEC in the same conditions. The increase in lactic acid content was apparent at 6 h of exposure and was maximal at 18 h (Figure 1).
|
Effect of Hypoxia and Hypoxia-Reoxygenation on Glucose Uptake
Exposure to hypoxia caused a large stimulation of glucose transport activity in AEC. The effect of hypoxia on glucose transport was O2 concentration-dependent: exposure to 5% and 0% O2 for the same period of time (18 h) increased DG uptake by 150 and 263%, respectively, as compared with normoxic control values (Figure 2A). As shown in Figure 2B, hypoxia-induced increase in DG transport was time-dependent: apparent at 6 h and maximal at 12 h with about a 4-fold increase above the baseline. Reoxygenation of the cells exposed to 0% O2 for 18 h resulted in a progressive decrease of DG uptake that reached the normoxic control values in 24 h. Hypoxia-induced stimulation of glucose transport was not related to a decrease of protein content because protein content was not different in normoxic and hypoxic cells except for cells exposed to 0% O2 18 h, in which protein content decreased 20 ± 2.4% when compared with normoxic cells. The hypoxia-induced stimulation of glucose transport was further examined by the kinetic analysis of the DG uptake in normoxia and hypoxia (Figure 3). Analysis of the Lineweaver- Burk plot showed that hypoxia increased the maximal velocity (Vmax) (100.06 nmol/mg protein/10 min compared with 41.06 nmol/mg protein/10 min in normoxia) without affecting the Michaelis content (Km) (4.34 and 3.44 mM in hypoxia and normoxia, respectively).
|
|
To be certain that the increase in DG uptake reflected an increase in transport and not a change in the efficiency of glucose phosphorylation, we measured initial rates of 3 OMG uptake, a glucose analog that is not phosphorylated by cells. In 2 min incubation, AEC accumulated 248 ± 10.2 pmol/mg protein in hypoxia, compared with 84.7 ± 4.8 pmol/mg protein in normoxia. Because glucose transport in AEC was also shown to occur through a Na-dependent pathway, we examined the uptake of MGP, a nonmetabolized analog of D-glucose, which competes with the latter on the Na-D-glucose cotransport system. As previously reported, MGP uptake was low in AEC exposed to normoxia (75.1 ± 2.5 pmol/mg protein/10 min) and did not change in cells exposed to 0% O2 for 18 h (85 ± 3.4 pmol/ mg protein/10 min).
Effect of Hypoxia on Glucose Consumption
AEC maintained for 18 h in 0% O2 consumed more glucose than in normoxia, inasmuch as the glucose concentration in the medium of hypoxic cells fell from 25 to 17 mM, whereas no significant change occurred in the medium of normoxic cells. To test whether, in AEC, hypoxia-induced increase in DG uptake might be ascribed to the decrease of extracellular glucose concentration, we compared DG uptake in cells cultured for 18 h in a low- (5 mM) or high- (25 mM) glucose concentration medium. No significant change in DG uptake was noted either in normoxia (9.35 ± 1.81 versus 7.28 ± 0.74 nmol/mg protein/10 min) or in hypoxia (21.18 ± 3.94 versus 28.51 ± 5.8 nmol/mg protein/10 min).
Effect of Protein Synthesis Inhibitor on Hypoxia-Induced DG Transport Increase
To test the possible involvement of de novo protein synthesis in upregulation of glucose transport, AEC were incubated for 18 h with 1 µM cycloheximide, a protein synthesis inhibitor, under either normoxia or hypoxia (0% O2). Cycloheximide completely blunted hypoxia-induced stimulation of DG uptake, suggesting that synthesis of glucose transporters or activator proteins is required for expression of hypoxia-induced stimulation of glucose transport (Figure 4).
|
Effect of Hypoxia on GLUT1 Protein Level
A recent study has shown that AEC maintained more than
2 d in culture mainly expressed the facilitated glucose transporter GLUT1 (10). The effect of hypoxia on the GLUT1
transporter was assessed by evaluation of the amount of
immunoreactive glucose transporter in total membranes
prepared from AEC incubated 18 h in 0% O2. Thirty micrograms of membrane protein of normoxic and hypoxic
cells were probed by Western blot analysis using antibodies directed against GLUT1 transporter. As seen in Figure
5, the amount of GLUT1 transporter in hypoxic cells was
markedly increased compared with that of cells exposed to
21% O2. The quantification by laser densitometry of GLUT1
transporter in three independent experiments, using
-actin
as standard, showed an average 3-fold increase in GLUT1
transporter in hypoxia as compared with the corresponding normoxic values.
|
Effect of Hypoxia and Hypoxia-Reoxygenation on GLUT1 mRNA Level
RPAs were performed in order to determine the level of GLUT1 mRNA transcript in normoxic and hypoxic cells. As shown in Figure 6, transcript encoding GLUT1 was detectable in AEC. Exposure of the cells to 0% O2 for 18 h induced a 3-fold increase in the GLUT1 mRNA level. When hypoxic cells were allowed to recover in 21% O2, a complete recovery in GLUT1 mRNA level was achieved in 24 h.
|
Effect of Cobalt Chloride and Inhibitor of Oxidative Phosphorylation on Glucose Transport and GLUT1 mRNA Levels
To determine whether upregulation of GLUT1 mRNA and glucose transport by hypoxia was directly related to O2 deprivation per se, or ascribed to hypoxia-induced inhibition of oxidative phosphorylation, we examined the effects of cobalt chloride and of Na azide, an inhibitor of oxidative phosphorylation, respectively. AEC incubated in the presence of 21% O2 with 100 µM cobalt chloride for 18 h demonstrated an ~ 2-fold stimulation in the 2DG uptake and an ~ 4-fold increase in GLUT1 mRNA level compared with control cells incubated under normoxic conditions. Incubation of the cells with 1 mM azide for 18 h produced a 3-fold increase in 2DG uptake and an ~ 2-fold increase in GLUT1 mRNA level (Figure 7).
|
Analysis of HIF DNA Binding Activity
HIF DNA binding activity was determined by electrophoretic mobility shift assay (EMSA) with probe GLUT1, a double-stranded oligonucleotide containing a 24-base pair sequence from the rat GLUT1 gene enhancer that mediates hypoxia-inducible transcription. Nuclear extracts obtained from AEC exposed to 21 and 0% O2 for 6 h, and cells incubated with 100 µM cobalt chloride for 6 h, were incubated with 32P-labeled probe. EMSA revealed that AEC exhibited HIF DNA binding activity in 21% O2, which increased in hypoxia and after cobalt chloride treatment (Figure 8).
|
| |
Discussion |
|---|
|
|
|---|
Our data show that AEC were fairly tolerant to prolonged hypoxia, inasmuch as they maintained their energy status at a level close to that of normoxic cells. Indeed, ATP content showed an early drop followed by a rapid return to normoxic control values. This ATP recovery roughly paralleled lactate content increase, suggesting that a drop in ATP content triggered increased anaerobic glycolysis which, in turn, put back the ATP level of hypoxic cells. These results agree with in vivo studies showing that rat lung tissue was not damaged by alveolar hypoxia and that it maintained a normal energy status under important oxygen deprivation (11).
In AEC, the first limiting step in glucose use is its transport across the membrane because glucose concentration
is low and activity of glycolytic enzymes largely exceeds
the rate of glucose utilization. This study demonstrated
that in AEC, glucose transport was upregulated in response to hypoxia. This stimulation involved only the Na-independent glucose transport, as shown by the dramatic increase in 2DG, but did not change the Na-dependent
glucose transport, evaluated by MGP uptake, a glucose analog that is transported only by the Na-dependent glucose
transporter. Hypoxia-induced increase in glucose transport increase was (1) time-dependent: observed for prolonged periods of hypoxia (
6 h); (2) O2 concentration- dependent: induced by moderate oxygen deprivation (5%
O2) and maximal for severe hypoxia (0% O2); and (3) reversible when the cells were allowed to reoxygenate in
normoxic atmosphere for 24 h. Hypoxia-induced stimulation of DG uptake was not the consequence of an increase
in intracellular phosphorylation because hypoxia induced
a similar increase in 3 OMG uptake, a glucose analog that is not phosphorylated. In mammalian tissues, facilitative
glucose transporters consist in five isoforms. The ubiquitous glucose transporter GLUT1, which is responsible in
most of the tissues for the basal glucose uptake, is largely
prominent in cultured AEC (10). In our study, prolonged
hypoxia induced an increase in the GLUT1 protein expression and in GLUT1 mRNA levels. A causative link
between increases in mRNA levels and protein expression
of GLUT1, and stimulation of glucose transport, was supported by the following evidence: (1) the time course of
hypoxia effect, with no substantial change before 6 h exposure; (2) the prevention of hypoxia-induced DG stimulation by cycloheximide, an inhibitor of translation; and (3)
the parallel recovery during reoxygenation in DG uptake
and GLUT1 mRNA level. Comparison of AEC with other hypoxic-tolerant cells showed that they resemble endothelial cells (12) but differ from heart and skeletal muscle, in
which the upregulation of glucose transport is an early event
(
1 h) with no change of GLUT1 mRNA level (13, 14).
The nature of the signal by which hypoxia triggers the increase in GLUT1 mRNA level has been addressed. GLUT1 belongs to the glucose-regulated protein family of stress proteins, and both GLUT1 protein and mRNA levels have been shown to be upregulated by glucose starvation (15, 16). In our study, upregulation of GLUT1 transporter was not the consequence of hypoxia-induced glucose deprivation because (1) cells were cultured in a high glucose concentration medium, and after 18 h of exposure to 0% O2 the glucose concentration in the medium did not fall below 17 mM; and (2) glucose transport activity was not different in cells cultured in low glucose concentration (5 mM) medium compared with cells grown in high glucose concentration (25 mM) medium. The glucose transporter GLUT1 gene also belongs to the family of hypoxia-regulated genes. In different nonepithelial cell lines, GLUT1 mRNA expression was reported to be upregulated by O2 deprivation (9, 12, 17). In our study GLUT1 mRNA accumulation was induced by hypoxia and reversed by a following exposure to normoxia, suggesting that in primary alveolar epithelial cells, as well as in nonepithelial cells, upregulation of GLUT1 expression was regulated by O2 deprivation. The O2 sensing mechanisms whereby hypoxia regulates GLUT1 mRNA transcripts are not univocal and may result from either reduced O2 concentration per se or inhibition of oxidative phosphorylation (9, 17). This distinction can be made through employment of specific chemical agents that mimic the actions of the different components of the hypoxic response. Cobalt chloride, employed in the presence of oxygen, mimics the effects of lowered oxygen concentration per se. In normoxic AEC, cobalt chloride induced an increase of both GLUT1 mRNA levels and DG uptake. Na azide, an inhibitor of oxidative phosphorylation used in the presence of oxygen, was as effective as hypoxia to stimulate glucose transport but induced a lesser increase in GLUT1 mRNA levels. Further studies are required to determine the temporal and spatial contributions of these two mechanisms in hypoxia-induced upregulation of GLUT1 mRNA level.
Recent studies have clearly demonstrated that hypoxia-inducible GLUT1 expression is critically dependent on the
binding of a nuclear protein, HIF-1, to the hypoxia-inducible DNA element (HIE) upstream of the GLUT1 gene (9,
17). HIF-1 is a heterodimer composed of HIF1-
and
HIF1-
subunits, both of which are members of the basic-helix-loop-helix-PAS (bHLH/PAS) family of proteins (18):
HIF1-
is a protein unique to HIF-1; whereas HIF1-
is identical to the aryl hydrocarbon nuclear translocator that
can heterodimerize with several other proteins, including
the aryl hydrocarbon receptor (19) and other bHLH/PAS
proteins such as endothelial PAS protein-1 (EPAS1) (20,
21). Both HIF1-
and HIF1-
subunits are instrumental in
activating the GLUT1 gene in response to O2 deprivation
(22, 23). In our study AEC expressed a constitutive level of
HIF-1 DNA binding, the activity of which increased under
hypoxic exposure and after cobalt chloride treatment. In
most of the cell lines, HIF-1 DNA binding was clearly dependent on O2 concentrations with low or undetectable activity in normoxia and with a maximum increase for very
low O2 concentrations (0.5% O2) (24). However, the presence of high constitutive levels of HIF DNA binding has already been reported in a few cell types, such as pulmonary
arterial smooth muscle cell (25), J1 embryonic stem cells
(22), and v-Src-transformed rat fibroblasts (26), but its significance is not clearly understood. One possibility is that
cultured cells exposed to normoxic atmosphere were in relatively hypoxic conditions due to the presence of culture
medium above them. The second possibility is that the high
basal HIF-1 DNA binding may be adaptive in cells with increased metabolic demands and, in this case, a signal transduction pathway that if not hypoxia-driven could upregulate HIF-1 expression in a cell type-specific manner.
Finally, it could not be excluded that the nuclear protein
that bound to the probe was not HIF-1 but an HIF-like factor. EPAS is an HIF that exhibits very similar characteristics to HIF1-
in the properties of dimerization, DNA binding, and transcriptional activation (20, 27). EPAS was less
ubiquitously expressed than HIF1-
and mainly regulated
the transcription of vascular endothelial growth factor (21).
In AEC, EPAS might be a good candidate because: (1)
EPAS-1 was more active in normoxia and less inducible by
hypoxia than HIF-1 (20); and (2) EPAS mRNA transcript
was expressed in mice alveolar epithelium at a higher level
than HIF1-
mRNA (21). Further studies are required to
determine whether EPAS is involved in the transcriptional
regulation of the GLUT1 gene.
In conclusion, AEC regulate the GLUT1 transporter at the transcriptional level in response to hypoxia, a phenomenon that allows them to maintain their main functions. This regulation involves, at least in part, HIFs, the nature of which remains to be determined. Further studies should be useful in determining their physiologic roles and their specific regulation.
| |
Footnotes |
|---|
Address correspondance to: Christine Clerici, M.D., Ph.D., Dept. of Physiology, Faculté Léonard de Vinci, 54 rue Marcel Cachin, 93012 Bobigny cedex, France. E-mail: christine.clerici{at}avc.ap-hop-paris.fr
(Received in original form March 30, 1999 and in revised form June 8, 1999).
Abbreviations: alveolar epithelial cells, AEC; adenosine triphosphate, ATP; 2-deoxy-D-glucose, DG; ethylenediaminetetraacetic acid, EDTA; endothelial PAS protein, EPAS; N-2-hydroxyethylpiperazine-N'-2-ethane sulfonic acid, Hepes; hypoxia-inducible factor, HIF;
-methyl-glucopyranoside, MGP; messenger RNA, mRNA; 3-O-methyl glucose, 3 OMG;
phosphate-buffered saline, PBS; packed-cell volume, PCV; ribonuclease
protection assay, RPA; standard error, SE.
Acknowledgments: The authors are grateful to Pr. Gérard Friedlander for critically reading the manuscript and Dr. Georges Saumon for supplying the primers for the GLUT1 gene. This work was supported by grants from University Paris 13 and Fondation Pour la Recherche Médicale.
| |
References |
|---|
|
|
|---|
1.
Planès, C.,
B. Escoubet,
M. Blot-Chabaud,
G. Friedlander,
N. Farman, and
C. Clerici.
1997.
Hypoxia downregulates expression and activity of epithelial sodium channels in rat alveolar epithelial cells.
Am. J. Respir. Cell Mol.
Biol.
17:
508-518
2. Simon, L. M., E. D. Robin, T. Taffin, J. Theodore, and W. H. J. Douglas. 1978. Bioenergetic pattern of isolated type II pneumocytes in air and during hypoxia. J. Clin. Invest. 61: 1232-1239 .
3.
Hochachka, P. W.,
L. T. Buck,
C. J. Doll, and
S. C. Land.
1996.
Unifying
theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack.
Proc. Natl. Acad. Sci. USA
93:
9493-9498
4. Webster, K. A.. 1987. Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscles cells. Mol. Cell. Biochem. 77: 19-28 [Medline].
5. Perez-Diaz, J., A. Martin-Requero, M. S. Ayuso-Parrila, and R. Parilla. 1977. Metabolic features of isolated rat lung cells: I. Factors controlling glucose utilization. Am. J. Physiol. 232: E394-E400 .
6. Clerici, C., P. Soler, and G. Saumon. 1991. Sodium-dependent phosphate and alanine transports but sodium-independent hexose transport in type II alveolar epithelial cells in culture. Biochim. Biophys. Acta 1063: 27-35 [Medline].
7.
Dobbs, L. G..
1990.
Isolation and culture of alveolar type II cells.
Am. J. Physiol.
258:
L134-L147
8.
Semenza, G. L., and
G. L. Wang.
1992.
A nuclear factor induced by hypoxia
via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation.
Mol. Cell. Biol.
12:
5447-5454
9.
Behrooz, A., and
B. F. Ismail.
1997.
Dual control of glut1 glucose transporter gene expression by hypoxia and by inhibition of oxidative phosphorylation.
J. Biol. Chem.
272:
5555-5562
10. Saumon, G., and Y. Makhloufi. 1997. Glucose transporter gene expression in rat lung and alveolar type II cells in primary culture. Am. J. Respir. Crit. Care Med. 155: A831 .
11. Fisher, A. B., R. W. Hyde, and J. S. Reif. 1972. Insensitivity of the alveolar septum to local hypoxia. Am. J. Physiol. 223: 770-776 .
12.
Loike, J. D.,
L. Cao,
J. Brett,
O. Ogawa,
S. C. Silverstein, and
D. Stern.
1992.
Hypoxia induces glucose transporter expression in endothelial cells.
Am. J. Physiol.
263:
C326-C333
13.
Cartee, G. D.,
A. G. Douen,
T. Ramlal,
A. Klip, and
J. O. Holloszy.
1991.
Stimulation of glucose transport in skeletal muscle by hypoxia.
J. Appl. Physiol.
70:
1593-1600
14.
Xia, Y.,
J. B. Warshaw, and
G. G. Haddad.
1997.
Effect of chronic hypoxia
on glucose transporters in heart and skeletal muscle of immature and adult
rats.
Am. J. Physiol.
273:
R1734-R1741
15.
Wertheimer, E.,
S. Sasson,
E. Cerasi, and
Y. Ben-Neriah.
1991.
The ubiquitous glucose transporter GLUT-1 belongs to the glucose-regulated protein
family of stress-inducible proteins.
Proc. Natl. Acad. Sci. USA
88:
2525-2529
16. Simmons, R. A., A. S. Flozak, and E. S. Ogata. 1993. Glucose regulates glut 1 function and expression in fetal rat lung and muscle in vitro. Endocrinology 132: 2312-2318 [Abstract].
17.
Ebert, B. L.,
J. D. Firth, and
P. J. Ratcliffe.
1995.
Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct
Cis-acting sequences.
J. Biol. Chem.
270:
29083-29089
18.
Wang, G. L.,
B. H. Jiang,
E. A. Rue, and
G. L. Semenza.
1995.
Hypoxia-
inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated
by cellular O2 tension.
Proc. Natl. Acad. Sci. USA
92:
5510-5514
19.
Hoffman, E. C.,
H. Reyes,
F. F. Chu,
F. Snader,
L. H. Canley,
B. A. Brooks, and
O. Hankinson.
1991.
Cloning of a factor required for activity of the Ah
(dioxin) receptor.
Science
252:
954-958
20.
Wiesener, M. S.,
H. Turley,
W. E. Allen,
C. Willam,
K. U. Eckardt,
K. L. Talks,
S. M. Wood,
K. C. Gatter,
A. L. Harris,
C. W. Pugh,
P. J. Ratcliffe, and
P. H. Maxwell.
1998.
Induction of endothelial PAS domain protein-1
by hypoxia: characterization and comparison with hypoxia-inducible factor-1 alpha.
Blood
92:
2260-2268
21.
Ema, M.,
S. Taya,
N. Yokotani,
K. Sogawa,
Y. Matsude, and
Y. Fujii-Kuriyama.
1997.
A novel bHLH-PAS factor with close sequence similarly
to hypoxia-inducible factor 1 alpha regulates the VEGF expression and is
potentially involved in lung and vascular development.
Proc. Natl. Acad.
Sci. USA
94:
4273-4278
22.
Iyer, N. V.,
L. E. Kotch,
F. Agani,
S. W. Leung,
E. Laughner,
R. H. Wenger,
M. Gassmann,
J. D. Gearhart,
A. M. Lawler,
A. Y. Yu, and
G. L. Semenza.
1998.
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.
Genes Dev.
12:
149-162
23. Maltepe, E., J. V. Schmidt, D. Baunoch, C. A. Bradfield, and M. C. Simon. 1997. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature 386: 403-407 [Medline].
24.
Jiang, B. H.,
G. L. Semenza,
C. Bauer, and
H. H. Marti.
1996.
Hypoxia-
inducible factor 1 levels vary exponentially over a physiologically relevant
range of O2 tension.
J. Biol. Chem.
271:
32253-32259
25.
Yu, A. Y.,
M. G. Frid,
L. A. Shimoda,
C. M. Wiener,
K. Stenmark, and
G. L. Semenza.
1998.
Temporal, spatial, and oxygen-regulated expression
of hypoxia-inducible factor-1 in the lung.
Am. J. Physiol.
275:
L818-L826
26.
Jiang, B. H.,
F. Agani,
A. Passaniti, and
G. L. Semenza.
1997.
V-Src induces
expression of hypoxia-inducible factor 1 (HIF-1) and transcription of genes
encoding vascular endothelial growth factor and enolase1: involvement of
HIF-1 in tumor progression.
Cancer Res.
57:
5328-5335
27.
Rourke, J. F.,
Y. M. Tian,
P. J. Ratcliffe, and
C. W. Pugh.
1999.
Oxygen-regulated and transactivating domains in endothelial PAS protein 1: comparison with hypoxia-inducible factor 1 alpha.
J. Biol. Chem.
274:
2060-2071
This article has been cited by other articles:
![]() |
L. Chen, K. Uchida, A. Endler, and F. Shibasaki Mammalian Tumor Suppressor Int6 Specifically Targets Hypoxia Inducible Factor 2{alpha} for Degradation by Hypoxia- and pVHL-independent Regulation J. Biol. Chem., April 27, 2007; 282(17): 12707 - 12716. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Veschini, D. Belloni, C. Foglieni, M. G. Cangi, M. Ferrarini, F. Caligaris-Cappio, and E. Ferrero Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib Blood, March 15, 2007; 109(6): 2565 - 2570. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bouvry, C. Planes, L. Malbert-Colas, V. Escabasse, and C. Clerici Hypoxia-Induced Cytoskeleton Disruption in Alveolar Epithelial Cells Am. J. Respir. Cell Mol. Biol., November 1, 2006; 35(5): 519 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jain and J. I. Sznajder Effects of Hypoxia on the Alveolar Epithelium Proceedings of the ATS, October 1, 2005; 2(3): 202 - 205. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Krick, B. G. Eul, J. Hanze, R. Savai, F. Grimminger, W. Seeger, and F. Rose Role of Hypoxia-Inducible Factor-1{alpha} in Hypoxia-Induced Apoptosis of Primary Alveolar Epithelial Type II Cells Am. J. Respir. Cell Mol. Biol., May 1, 2005; 32(5): 395 - 403. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shimba, T. Wada, S. Hara, and M. Tezuka EPAS1 Promotes Adipose Differentiation in 3T3-L1 Cells J. Biol. Chem., September 24, 2004; 279(39): 40946 - 40953. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uchida, F. Rossignol, M. A. Matthay, R. Mounier, S. Couette, E. Clottes, and C. Clerici Prolonged Hypoxia Differentially Regulates Hypoxia-inducible Factor (HIF)-1{alpha} and HIF-2{alpha} Expression in Lung Epithelial Cells: IMPLICATION OF NATURAL ANTISENSE HIF-1{alpha} J. Biol. Chem., April 9, 2004; 279(15): 14871 - 14878. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Burke, A. Giannoudis, K. P. Corke, D. Gill, M. Wells, L. Ziegler-Heitbrock, and C. E. Lewis Hypoxia-Induced Gene Expression in Human Macrophages: Implications for Ischemic Tissues and Hypoxia-Regulated Gene Therapy Am. J. Pathol., October 1, 2003; 163(4): 1233 - 1243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Vivona, M. Matthay, M. B. Chabaud, G. Friedlander, and C. Clerici Hypoxia Reduces Alveolar Epithelial Sodium and Fluid Transport in Rats . Reversal by beta -Adrenergic Agonist Treatment Am. J. Respir. Cell Mol. Biol., November 1, 2001; 25(5): 554 - 561. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Clerici and M. A. Matthay Hypoxia regulates gene expression of alveolar epithelial transport proteins J Appl Physiol, May 1, 2000; 88(5): 1890 - 1896. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chen, N. Pore, A. Behrooz, F. Ismail-Beigi, and A. Maity Regulation of glut1 mRNA by Hypoxia-inducible Factor-1. INTERACTION BETWEEN H-ras AND HYPOXIA J. Biol. Chem., March 16, 2001; 276(12): 9519 - 9525. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. |